top of page

Australasian Clinical Tuberculosis Network

Welcome to our network dedicated to advancing tuberculosis
clinical research across Australia and New Zealand

ACTnet Steering Committee

The ACTnet steering committee consists of infectious diseases physicians and researchers who specialise in tuberculosis.

Dr Greg Fox 
Greg headshot.jpg

Associate Professor Greg Fox is a respiratory physician, epidemiologist, and clinical trialist committed to using research to improve health care among disadvantaged populations. He is clinical Academic Lead (Research) for the Faculty of Medicine and Health at Cumberland Campus. His research focuses on the detection and prevention of tuberculosis (TB). Greg's ongoing work ranges from community-wide cluster randomised trials and clinical trials to meta-analysis and evidence-based policy development. Dr Fox is a NHMRC Career Development Fellow and Associate Professor in Respiratory Medicine at Sydney University.

Dr Andrew Burke 

Dr Andrew Burke is a dual infectious disease and respiratory medicine specialist at The Prince Charles Hospital in Brisbane. His research interests include pharmacokinetics and drug dosing of mycobacterial drugs in tuberculosis and non-tuberculous mycobacterial infection, and he is affiliated with the University of Queensland Centre for Clinical Research. He has worked in TB programs in overseas settings and Australia and is on the World Health Organisation Technical Advisory Group for TB Drug Dosing. He is the current chair of the ACTnet steering committee.

Dr Alice Sawka
Alice Sawka head shot  2.jpg

Dr Alice Sawka is a respiratory physician at the Royal Adelaide Hospital. In 2021 she completed a clinical fellowship in mycobacterial disease at the Princess Alexandra Hospital in Brisbane. As a tuberculosis consultant with South Australian Tuberculosis Services, she is currently part of a team working to address the evolving TB outbreak in the APY lands and within other vulnerable populations in South Australia.  She holds a Master of Public Health from Monash University.

Dr Jack Callum

Dr Jack Callum is an Australian Respiratory and TB physician at Homerton Hospital in East London. Dr Callum has a Diploma in Tropical Medicine and Public Health and has clinical and research experience in Australia, the UK, Timor Leste, Vanuatu and Vietnam. He has published research in TB genomics and TB drug resistance whilst currently conducting research in TB drug-induced liver injury. He has hosted the ACTNet TB podcast for the past two years and is writing chapters for Oxford Clinical Medicine Textbook and Collin’s Respiratory Medicine textbook. Jack is passionate about building global networks and collaborations to achieve the WHO end TB goals.

Dr Gail Cross

Dr Gail Cross is an infectious disease physician who has worked around Australia, PNG and Singapore. She is completing her PhD through the Kirby Institute, UNSW based on the recently completed adjunctive rosuvastatin for tuberculosis treatment trial. She is interested in host-directed therapy, biomarker discovery in tuberculosis and health equity.  She currently resides in  Melbourne, Victoria, Australia with her family. 

Dr Simone Barry

Dr Simone Barry is a respiratory physician at Royal Adelaide Hospital. She is the Head of the SA Tuberculosis Service and, commensurate with that position, serves as the state representative for the National TB Advisory Committee, which provides expert advice to the Australian Government on the prevention and control of TB. She holds a Master's degree in Public Health and Tropical Medicine and her Ph.D. doctoral thesis examined microRNA as a biomarker for TB.  

Dr Mitzi Nisbet

Dr Mitzi Nisbet is an Infectious Diseases and Respiratory Physician and the Respiratory TB Clinical Lead at Te Toka Tumai, Health New Zealand in Auckland. She chairs the New Zealand MDR TB Clinical Network and has enjoyed opportunities to review TB programs and support guideline development in the Pacific region.

Dr Victoria Grey

Dr Victoria Grey is an infectious diseases physician at Logan Hospital and the Metro South Clinical Tuberculosis Service. She completed a mycobacterial fellowship in 2023 at the Princess Alexandra Hospital. She holds a Master of Public Health from Griffith University. Her research interests include central nervous system tuberculosis and therapeutic drug monitoring in mycobacterial disease. She is passionate about health equity including improving healthcare access to vulnerable populations. She currently resides in Brisbane. 

Dr Catherine Berry
bottom of page